Last Updated: Apr 07, 2016
- BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.
Mundhofir Farmaditya Ep et al. Asian Pacific journal of cancer prevention : APJCP 2016 17(3) 1539-46 - Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
Appel Susan J et al. Journal of National Black Nurses' Association : JNBNA 2015 Dec 26(2) 17-26 - Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Riahi Aouatef et al. Breast cancer (Tokyo, Japan) 2016 Mar - Who Should Consider Genetic Counseling and Testing for Breast and Ovarian Cancer? : Guidelines Have Expanded,
My Gene Counsel, April 5, 2016 - BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
Unni Sudhir K et al. Journal of ovarian research 2016 9(1) 18 - Tier 1 Genomic Applications Toolkit for Public Health Departments
Disease: Multiple Diseases; Type: Tools; State: Multiple States - The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.
Huzarski T, et al. Breast cancer research and treatment 2016 3 - CAG repeat size in Huntingtin alleles is associated with cancer prognosis.
Thion Morgane Sonia, et al. European journal of human genetics : EJHG 2016 3 - Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Tung Nadine, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 3 - Non-Neoplastic Conditions of the Ovaries in Grossly Normal Adnexa: A Clinicopathologic Study of 403 Completely Embedded Cases.
Seidman Jeffrey D, et al. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2016 3 - FORCE family letter for BRCA1 and BRCA2 carriers
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer (HBOC) Genes in Patients Lacking known BRCA Mutations.
Caminsky Natasha G, et al. Human mutation 2016 2 - Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations.
Mostowska Adrianna, et al. Oncology letters 2016 2 (2) 1181-1188 - Kintalk Instructional Video
Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Talking about BRCA in your family tree
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - FORCE Letter to Relatives about Genetic Mutation
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Cancerous leptomeningitis and familial congenital hypopituitarism.
Vujovic S, et al. Endocrine 2016 2 - Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer.
Song Zhi-Shuang, et al. Oncology letters 2016 1 (1) 194-200 - Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
Cini Giulia, et al. BMC medical genetics 2016 0 (1) 11 - Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.
Cao Wen-Ming, et al. BMC cancer 2015 0 (1) 64 - Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Published on 2016 by National Comprehensive Cancer Network - Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Kim Yeong C, et al. Oncotarget 2016 2 - Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.
Swisher Elizabeth M, et al. JAMA oncology 2016 2 - Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment and pathology report.
Mauro Signorelli, et al. Minerva ginecologica 2016 2 - Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland.
Wojcik P, et al. Hereditary cancer in clinical practice 2016 0 5 - BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.
Nielsen Henriette Roed, et al. Familial cancer 2016 2 - Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Sabatier Renaud, et al. Familial cancer 2016 2 - Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.
Garcia Amandine I, et al. European journal of human genetics : EJHG 2016 1 - Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.
Quiles Francisco, et al. Breast cancer research and treatment 2016 1 - BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
?awniczak Ma?gorzata, et al. Hereditary cancer in clinical practice 2016 0 3
- Hot Topics (30)
- Genomics & Health Impact Scan (0)
- AMD Weekly Clips (0)
- HuGE (667)
- AMD Weekly Clips (0)
- Weekly Scan (126)
- AMD Weekly Clips (0)
.png)
No hay comentarios:
Publicar un comentario